•The UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Wegovy pill (semaglutide tablets) as the first daily oral treatment for weight management.
•Novo Nordisk anticipates the Wegovy pill will be available via private prescription in the UK within weeks.
•Dana announced a definitive agreement to combine with Eaton's Mobility business in a transaction valued at approximately $5.1 billion.
•The deal is structured as a Reverse Morris Trust, resulting in Eaton shareholders owning 50.1% and Dana shareholders owning 49.9% of the combined company.
•The combined company is expected to generate approximately $11 billion in sales and achieve $250 million in run-rate synergies within 24 months.
